Identifying attitudinal barriers to family management of cancer pain in palliative care in Taiwan

Lin, C-C.; Wang, P.; Lai, Y-L.; Lin, C-L.; Tsai, S-L.; Chen, T.T.
November 2000
Palliative Medicine;Nov2000, Vol. 14 Issue 6, p463
Academic Journal
Abstract: The purpose of this study was threefold: (1) to examine attitudes held by Taiwanese family caregivers of hospice inpatients with cancer that serve as barriers to cancer pain management; (2) to determine the relationship of attitudinal barriers to family caregiver hesitancy to report pain and to administer analgesics; and (3) to determine the relationship of attitudinal barriers to the adequacy of analgesics used by the patient. A total of 80 pairs of palliative care inpatients and their primary family caregivers participated in this study. Family caregivers completed the Barriers Questionnaire–Taiwan (BQT) form and a demographic questionnaire. The instruments completed by patients consisted of the Brief Pain Inventory–Chinese version and a demographic questionnaire. The data revealed that Taiwanese family caregivers of palliative care patients with advanced cancer had concerns about reporting pain and administering analgesics, particularly as they related to disease progression, side-effects and p.r.n. analgesics. Older and less-educated family caregivers scored significantly higher on the BQT than did their younger, more educated counterparts. Family caregivers‘ concerns measured by the BQT were related to family caregivers‘ reluctance to administer analgesics to their patients. Implications for a broader understanding of analgesics in the advancement of pain management in palliative care in Taiwan are discussed.


Related Articles

  • Attitudes and knowledge about cancer pain in Flanders. The educational effect of workshops regarding pain and symptom control. Bauwens, S.; Distelmans, W.; Storme, G.; Kaufman, L. // Palliative Medicine;May2001, Vol. 15 Issue 3, p181 

    Despite international agreements and recommendations regarding cancer pain therapy, the effectiveness of pain treatment is still a major problem even in Western countries. Part of the problem is that physicians and nurses often lack knowledge of methods for the assessment and treatment of cancer...

  • Plans to increase access to pain relief in developing countries.  // PharmacoEconomics & Outcomes News;9/4/2010, Issue 611, p10 

    The article reports on the plan of cancer pain advocates to raise the accessibility of cheaper pain relief drugs in developing countries.

  • Evidence-Based Standards for Cancer Pain Management. Naga, Bilal S. H. Badr // Middle East Journal of Family Medicine;Oct2015, Vol. 13 Issue 7, p41 

    Cancer pain management is the most problematic when found in patients who have a malignant tumor, and represents the most feared consequences for patients and their families. A thorough literature review was conducted using the electronic databases of CINAHL, EBSCO, MEDLINE, and PUB MED, for...

  • Knowledge: Insufficient for Change. Ferris, Frank D.; von Gunten, Charles F.; Emanuel, Linda L. // Journal of Palliative Medicine;Jun2001, Vol. 4 Issue 2, p145 

    Editorial. Discusses the role of education in cancer pain management. Steps of educational evaluation to change patient and family experience; Overview of projects using educational means to cancer pain management; Limitation of educational effort focusing on skill development.

  • Intrathecal chemical neurolysis for intractable cancer pain: a retrospective audit of 39 patients at a specialized cancer centre. Rehman, Saad Ur; Khan, Muhammad Zafar; Ahmed, Yaasir Ijaz; Rehman, Abdul // Anaesthesia, Pain & Intensive Care;Jul-Sep2015, Vol. 19 Issue 3, p287 

    Objectives: Treatment of cancer pain presents a challenging problem. Up to 90% of cancer patients can be treated with conventional pharmacological therapy. The remaining 10% of patients require additional interventions for management of their pain. Intrathecal chemical neurolysis (ICN) is a...

  • Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain. Zeppetella, G. // Palliative Medicine;Jan2000, Vol. 14 Issue 1, p57 

    Studies the use of nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain. Case histories of cancer patients with breakthrough pain; Overview of breakthrough pain; Ideal delivery systems for breakthrough analgesia; Comparison of fentanyl effectiveness and...

  • Intravenous morphine for rapid control of severe cancer pain. Harris, J T; Suresh Kumar, K; Rajagopal, M R // Palliative Medicine;Apr2003, Vol. 17 Issue 3, p248 

    This randomized controlled trial compared intravenous route with oral route for initial dose titration of morphine in 62 patients with end-stage cancer and severe pain. Patients in the intravenous group received 1.5 mg intravenous bolus doses of morphine every ten minutes till pain relief was...

  • Hospice workers fill a vital role. Bailey, Janet // Clarendon Enterprise (TX);10/28/2010, Vol. 21 Issue 43, p2 

    In this article, the author discusses the effort of hospice workers to establish effective pain management in the U.S. in 2010.

  • An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Mercadante, Sebastiano; Villari, Patrizia; Casuccio, Alessandra // Supportive Care in Cancer;Jul2011, Vol. 19 Issue 7, p979 

    recognition and treatment of breakthrough cancer pain (BcP) depend on the education and knowledge of palliative care physicians, it is important to systematically explore the attitudes of palliative care physicians in hospices or palliative care units. The aim of this study was to assess the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics